Quarterly report [Sections 13 or 15(d)]

Asset Purchase and Merger Agreements - Support and Royalty Agreement (Details)

v3.25.1
Asset Purchase and Merger Agreements - Support and Royalty Agreement (Details) - shares
Mar. 31, 2025
Mar. 09, 2025
Royalty interests as percentage of net sales payable to fortress biotech   2.50%
Common stock, no class    
Number Of Shares Owned 6,222,249  
Class A common stock    
Number Of Shares Owned 700,000